Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - Primary Care Today 2013
Update on Benign Prostatic Hyperplasia in Primary Care
Toronto, Ontario / May 9-11, 2013
Toronto - Lower urinary tract symptoms (LUTS) in older males are a common clinical problem and are often secondary to the development of benign prostatic hyperplasia (BPH). Treatment goals include a reduction in daytime frequency, hesitancy...
PHYSICIAN PERSPECTIVE - Viewpoint based on presentations and expert opinion from the New York Academy of Sciences (NYAS) Probiotics, Prebiotics, and the Host Microbiome: The Science of Translation and the 11th Annual Meeting of the International Scientific Association for Probiotics and Prebiotics (ISAPP)
The Microbiome and the Brain-Gut Axis: A Role for Prebiotics and Probiotics
New York, New York / June 12-14, 2013
Reviewed and Edited by:Eamonn Quigley, MD Chief, Division of Gastroenterology and Hepatology The Methodist Hospital and Weill Cornell College of MedicineHouston, Texas IntroductionThe influence of gut microbiota on hormone and...
PRIORITY PRESS - SLEEP 2013 - 27th Annual Meeting of the Associated Professional Sleep Societies
Sleep-Wake Systems Intersected: A New Dawn in the Treatment of Sleep Disorders
Baltimore, Maryland / June 1-5, 2013
Baltimore - Insomnia is a common disorder frequently accompanied by comorbidities, most commonly depression. Historically, it was believed that difficulty in falling or maintaining sleep was due to abnormalities in the sleep system. It is...
PHYSICIAN PERSPECTIVE - Viewpoint based on literature: Rummel et al. Lancet 2013;381(9873):1203-10.
Therapies for Indolent Lymphomas: Progress in Efficacy and Tolerability
May 2013
Reviewed and Edited by: Laurie H. Sehn, MD, MPHClinical Associate ProfessorBC Cancer Agency andThe University of British ColumbiaVancouver, British Columbia Introduction Consensus about the optimal first-line approach to indolent...
PRIORITY PRESS - 23rd European Congress on Clinical Microbiology and Infectious Diseases
Serum Antifungal Concentrations Are Fundamental to Cure of Invasive Aspergillosis
Berlin, Germany / April 27-30, 2013
Berlin - The absence of strategies to ensure adequate antifungal drug levels for the treatment of invasive aspergillosis (IA) and other serious fungal diseases appears to be a major source of poor outcomes, judging from a series of studies...
PHYSICIAN PERSPECTIVE - Get with the PROTOCOL - A Regional Perspective on the Evidence and Resulting Changes in ACS Protocol
University of Ottawa Heart Institute
May 2013
Reviewed and edited by: Michel Le May, MD, FRCPCDirector, Coronary Care Unit, and University of Ottawa Heart Institute Regional STEMI ProgramProfessor of MedicineUniversity of Ottawa Heart InstituteOttawa, Ontario IntroductionAntiplatelet...
PRIORITY PRESS - Digestive Diseases Week 2013
Progress in Control of Constipation: Highly Specific Agents Change Treatment Algorithm
Orlando, Florida / May 18-21, 2013
Orlando - Pharmacologic control of constipation has improved as a result of progress in unraveling the brain-gut connection, according to data and expert opinion presented at the 2013 DDW meeting. Newer and emerging therapies are based on a...
PHYSICIAN PERSPECTIVE - Get with the GUIDELINES - A Regional Perspective on the Evidence and Resulting Changes in ACS Protocol
London Health Sciences Centre
May 2013
Reviewed and edited by: Dennis Humen, MD, FRCPCCardiologist London Health Sciences CentreProfessor of MedicineUniversity of Western Ontario London, Ontario IntroductionCare pathways that include antiplatelet therapy in the management of...
MEDICAL FRONTIERS - Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
New Comparative Data for Anti-VEGF Therapies in Age-Related Macular Degeneration
Seattle, Washington / May 5-9, 2013
Seattle - A head-to-head trial failed to demonstrate that bevacizumab matches the efficacy and safety of ranibizumab for the treatment of neovascular age-related macular degeneration (AMD). For the primary end point of the trial, presented...